Loading, please wait...
:

product description page

Mtor Inhibition for Cancer Therapy : Past, Present and Future (Hardcover)

Mtor Inhibition for Cancer Therapy : Past, Present and Future (Hardcover) - image 1 of 1

About this item

This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs.

Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compounds currently under evaluation.

Number of Pages: 400
Genre: Medical
Sub-Genre: Oncology
Format: Hardcover
Publisher: Springer Verlag
Language: English
Street Date: December 1, 2015
TCIN: 50920611
UPC: 9782817804910
Item Number (DPCI): 248-12-6393
If the item details above aren’t accurate or complete, we want to know about it. Report incorrect product info.

Guest reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.